“Biochemical, Hematological and Immunological Indices Among MDR-TB on Second Line Anti TB and MDR-TB-HIV Co-Infected Patients on Second Line Anti TB and ARV Drugs for a Six -Month Treatment”, TMJ, vol. 31, no. 3, pp. 1–14, Oct. 2020, doi: 10.4314/tmj.v31i3.359.